SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biomatrix (BXM) Looking Great
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John McCarthy who wrote (341)2/1/1998 2:26:00 PM
From: John McCarthy   of 569
 
Short Sales ..................

On CompusServe last week I caught an article indicating
that short sales of BIOX was at about 350,000 as of
1/15/98.

I have lost the information source so I cannot forward.

This level of short sales at this time is over my head.

(1) BIOX should report in the next 4 weeks.

(2) As you know, a boutique brokerage firm just praised
BIOX again, with a target of 40 for the next
6 months and 70 for the year.

A typical day of trades in BIOX is about 50-55 (000).

Given the upward volatility of this stock, I do not
understand the short-seller logic.

I would think that if BIOX reported anything higher than
$1.40 for the year, BIOX would go absolutely ballastic.

And, in a manner of speaking this is easy to do, because
AHP and them could have an agreement to ship X sales
for the 4th qtr. (This is SELL-IN as opposed to SELL-THRU)
i.e. Inventory build-up on AHP's part.

Any thoughts?

Regards,

John McCarthy
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News